Skinvisible, Inc. (SKVI)
Skinvisible, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.18, up 0.00% on the session, giving a market capitalisation of $972,692. On trailing twelve-month figures it carries a trailing P/E of -0.91, a net margin of -5251.1%. Its beta of 1.71 implies it has historically moved more than the broad market.
Skinvisible, Inc., together with its associated entities, specializes in the creation, production, and distribution of advanced polymer-based delivery system technologies. These proprietary systems facilitate the topical, transdermal, and mucosal application of active ingredients, serving various sectors including pharmaceuticals (both prescription and over-the-counter), personal skincare, and cosmetics. Beyond dermatological applications, the company's non-dermatological formulations address specific needs in women's health, pain management, and other diverse markets. Under the 'Skinbrella' brand, Skinvisible provides consumer products such as sunless tanning lotions and sunscreens. Their business model also encompasses licensing these technologies to pharmaceutical and consumer goods companies. Furthermore, they assist pharmaceutical clients with early-stage formulation development. A key service involves reformulating existing pharmaceutical products nearing patent expiration, utilizing their unique Invisicare patent to introduce new product benefits and facilitate line extensions. Incorporated in 1998, the company originally operated as Microbial Solutions, Inc. before adopting the name Skinvisible, Inc. in February 1999. It maintains its headquarters in Las Vegas, Nevada.
Skinvisible, Inc. is most often compared with the following Healthcare names: